# FDA Inspection 1195290 - Jamol Laboratories, Inc. - January 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/jamol-laboratories-inc/e9bb5ad7-4871-47b7-b164-1979160a61a2
Source feed: FDA_Inspections

> FDA Inspection 1195290 for Jamol Laboratories, Inc. on January 12, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195290
- Company Name: Jamol Laboratories, Inc.
- Inspection Date: 2023-01-12
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1256416 - 2024-12-12](https://www.keypedia.com/records/fda_inspections/jamol-laboratories-inc/dffde0d3-8c83-454b-933e-a813de9e074f)
- [FDA Inspection 980976 - 2016-08-03](https://www.keypedia.com/records/fda_inspections/jamol-laboratories-inc/b4206b79-b7da-4b19-8b57-64f15f9a9913)
- [FDA Inspection 828881 - 2013-04-24](https://www.keypedia.com/records/fda_inspections/jamol-laboratories-inc/4259fa1b-52f3-4def-bd0f-f6e3c1846edf)
- [FDA Inspection 715900 - 2011-03-28](https://www.keypedia.com/records/fda_inspections/jamol-laboratories-inc/ce5cd9f3-4dfa-4f3e-83f4-8ec5136f9609)

Company: https://www.keypedia.com/companies/jamol-laboratories-inc/acd4c51c-2154-464d-bbc0-01477a7e4917

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c